← Back
$CRVS All transactions

Corvus Pharmaceuticals, Inc.

A

$ Value

$0

Shares

15,000

Price

$0

Filed

Jun 16

Insider

Name

Thompson Peter A.

Title

CIK

0001357522

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-06-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,000

Footnotes

The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. | Pursuant to an agreement with OrbiMed Advisors LLC ("Advisors") and OrbiMed Capital GP V LLC ("GP V"), the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to Advisors and GP V, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V, LP.

Filing Info

Accession No.

0001610717-25-000230

Form Type

4

Issuer CIK

0001626971

Thompson Peter A.'s History

Date Ticker Type Value
2025-06-27 CRVS X $4.9M
2025-06-27 CRVS $4.9M
2025-06-27 CRVS X $0
2025-06-25 SPRY A $0
2025-06-16 EWTX A $0
2025-06-12 CRVS A $0
2025-06-12 SION A $0

Other Insiders at CRVS (90d)

No other insider activity at this issuer in the last 90 days.